True North Therapeutics
Latest round
- Series D
Last raised
- Oct 2016
Total raised
- $142M
Investors
- 14
About True North Therapeutics
True North Therapeutics, Inc.True North Therapeutics, Inc. was founded in 2013 in South San Francisco, US, focusing on enhancing medication access. In May 2017, Bioverativ Inc. acquired the company for USD 400 mn, with an additional USD 425 mn dependent on future milestones.True North Rx specializes in providing innovative healthcare solutions, focusing primarily on pharmacy benefit management services and pharmaceutical distribution. Their core offerings aim to streamline medication access for patients while optimizing costs for healthcare providers and payers. True North Rx serves a diverse client base, including health plans, employers, and healthcare providers, facilitating improved patient outcomes through effective medication management and adherence programs.True North Rx generates revenue primarily through its pharmacy benefit management services, which operate on a B2B model, catering to health plans and employers. The company employs a transaction structure based on service agreements and subscriptions, allowing clients to access its services through tailored packages. Their offerings include tiered pricing plans based on the volume of medications managed and the specific services utilized, ensuring flexibility for different client needs. Flagship services encompass comprehensive medication management systems, which help reduce overall healthcare costs while enhancing patient care., True North Therapeutics is poised to leverage the resources for further growth. The company is set to enhance its product offerings and expand their reach in the pharmaceutical market. True North aims to broaden its market presence across North America, targeting both urban and rural sectors by 2020. The most recent deal completed in May 2017 will allow True North to scale its operations effectively.
Who invested in True North Therapeutics
14 investors across 6 rounds
See all investors in True North Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about True North Therapeutics
Who invested in True North Therapeutics?
True North Therapeutics has 14 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has True North Therapeutics raised?
True North Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did True North Therapeutics last raise money?
True North Therapeutics's most recent round on record is a Series D, in Oct 2016.
What does True North Therapeutics do?
True North Therapeutics is a pharmaceuticals company.
Where is True North Therapeutics headquartered?
True North Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like True North Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at True North Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like True North Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.